心肌组织损伤的演变:ST段抬高型心肌梗死后十年心脏磁共振研究
研究对74例首发ST段抬高型心肌梗死并接受直接经皮冠状动脉介入治疗的患者进行系列心脏磁共振检查(第一周内及4个月、12个月、9年),发现梗死面积在所有时间点间进行性显著减小,平均年缩小率5.8%,十年相对缩小49%;9年时29%患者梗死核心内持续存在铁沉积,82%存在持续水肿,且与初始梗死严重程度和不良愈合相关。
要点
- 梗死面积在梗死后十年内持续动态缩小,平均年缩小率5.8%,十年相对缩小49%。
- 9年时29%患者梗死核心内可见铁沉积,82%存在持续水肿,提示愈合延迟。
- 持续铁沉积和水肿与更大梗死面积、微血管阻塞及更大的收缩末期容积相关。
核心结论
- 梗死面积的演变是一个动态过程,远超ST段抬高型心肌梗死后最初数月;梗死核心内铁和水肿可持续至梗死后十年,并与初始梗死严重程度和不良梗死愈合相关。
研究设计与样本
- 研究为对74例首发ST段抬高型心肌梗死并接受直接经皮冠状动脉介入治疗的患者进行系列心脏磁共振检查(第一周内及4个月、12个月、9年),评估左心室功能、梗死面积和微血管阻塞;9年时加做T2∗、T2和T1 mapping(n=59)以评估梗死核心内铁和水肿。
关键影像表现/征象
- 梗死面积在所有心脏磁共振时间点之间进行性显著减小(所有P < 0.001)。
- 基线时61%患者存在微血管阻塞,随访检查时均未再见微血管阻塞。
- 9年时59例中17例(29%)梗死核心内存在铁沉积,82%存在持续水肿。
- 59例中14例(24%)表现为T1低信号梗死核心且无T2∗铁沉积证据,归因于梗死区脂肪瘤样化生。
诊断标准与关键数值
- 梗死面积平均年缩小率5.8%(IQR:3.5%-8.8%),十年相对缩小49%(IQR:39%-76%)。
- 持续铁沉积和持续水肿均与任一时间点更大的梗死面积相关(所有P < 0.001),并与微血管阻塞存在相关(P < 0.001)。
- 持续铁沉积患者梗死面积相对消退更低(P = 0.005),持续水肿患者梗死面积相对消退也更低(P = 0.032)。
- 持续铁沉积和持续水肿患者十年内收缩末期容积更大(分别为所有P < 0.012和P > 0.023)。
临床应用与阅片要点
- 心脏磁共振随访可显示梗死面积在梗死后十年内持续缩小,阅片时不应将数月后的残留异常简单视为终末状态。
- 9年时梗死核心T1低信号且无T2∗铁沉积证据可能提示梗死区脂肪瘤样化生。
- 持续铁沉积和水肿与更大梗死面积及微血管阻塞相关,报告时可结合这些征象描述梗死愈合状态。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: In patients with a first ST-segment elevation myocardial infarction (STEMI), the multi-annual evolution of myocardial tissue injury parameters, as assessed by cardiac magnetic resonance (CMR), has not yet been described.
OBJECTIVES: This study examined myocardial tissue injury dynamics over a decade after STEMI.
METHODS: Sequential CMR examinations (within the first week after STEMI, and at 4, 12, months, and 9 years thereafter) were conducted in 74 patients with STEMI treated with primary percutaneous coronary intervention. Left ventricular function, infarct size (IS), and microvascular obstruction (MVO) were assessed at all time points. T2∗, T2, and T1 mapping (n = 59) were added at 9-year scan to evaluate the presence of iron and edema within the infarct core, respectively.
RESULTS: IS decreased progressively and significantly between all CMR time points (all P < 0.001), with an average reduction rate of 5.8% per year (IQR: 3.5%-8.8%) and a relative reduction of 49% (IQR: 39%-76%) over a decade. MVO was present in 61% of patients at baseline, but was not present at the follow-up examinations. At 9-year CMR, 17 of 59 (29%) patients showed iron deposition within the infarct core, whereas 82% had persistent edema. Persistent iron and edema were associated with greater IS on any occasion (all P < 0.001), as well as the presence of MVO (P < 0.001). Patients with persistent iron and edema showed a lower relative regression of IS (P = 0.005 and P = 0.032, respectively) and greater end-systolic volumes over a decade (all P < 0.012 and P > 0.023, respectively). A T1 hypointense infarct core without evidence of T2∗ iron deposition (14 of 59 [24%] patients) was attributed to lipomatous metaplasia of the infarct.
CONCLUSIONS: The evolution of IS is a dynamic process that extends well beyond the first few months after STEMI. Persistence of iron and edema within the infarct core occurs up to a decade after STEMI and is associated with initial infarct severity and poor infarct healing.
引用
- Mayr, Klug, Reindl, et al. Evolution of Myocardial Tissue Injury: A CMR Study Over a Decade After STEMI. JACC Cardiovasc Imaging. 2022. PMID: 35680211. doi:10.1016/j.jcmg.2022.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。